Introduction
============

The recent development of new medical imaging techniques, together with data from clinical investigations, has helped to identify the microcirculation as playing a key role in sepsis \[[@B1]\]. The array of pathogenic factors that occur in sepsis affects almost every cellular component of the microcirculation, including endothelial cells, smooth muscle cells, leukocytes, erythrocytes, and tissue cells. If not corrected directly, a poorly functioning microvasculature can lead to respiratory distress in tissue cells further fuelling microcirculatory dysfunction in a cascade of pathogenic mechanisms leading to organ failure (Fig. [1](#F1){ref-type="fig"}). Sakr and colleagues \[[@B2]\] showed that microcirculatory distress not corrected for 24 hours was the single independent factor predicting patient outcome. The central role of the microcirculation in providing oxygen to the tissue cells makes it of prime importance in determining organ function. Microcirculatory dysfunction persisting for extended periods of time can act as a motor driving the pathogenic effects of sepsis leading to organ failure in much the same way as the gut was considered to be the motor of multiorgan failure \[[@B3]\].

![The microcirculation is the motor of sepsis. Circulatory failure as a result of sepsis can be initiated by various insults such as trauma, infection, and shock. Its treatment is initially based on correction of systemic variables. Microcirculatory distress can persist and remain undetected, a condition termed microcirculatory and mitochondrial distress syndrome (MMDS). Here, time and therapy contribute to its definition and nature. Left uncorrected, the different cellular and inflammatory components of the distressed microcirculation interact and increase in severity, fueling the respiratory distress of the parenchymal cells and ultimately leading to organ failure.](cc3753-1){#F1}

The microcirculation
====================

Microcirculatory function is the main prerequisite for adequate tissue oxygenation and thus organ function. Its purpose is to transport oxygen and nutrients to tissue cells, ensure adequate immunological function and, in disease, to deliver therapeutic drugs to target cells. The microcirculation consists of the smallest blood vessels (\<100 μm diameter) where oxygen release to the tissues takes place, and consists of arterioles, capillaries, and venules. The main cell types comprising the microcirculation are the endothelial cells lining the inside of the microvessels, smooth muscle cells (mostly in arterioles), red blood cells, leukocytes, and plasma components in blood. The structure and function of the microcirculation is highly heterogeneous in different organ systems. In general, driving pressure, arteriolar tone, hemorheology, and capillary patency are the main determinants of capillary blood flow.

Regulation of the microcirculation
----------------------------------

The regulatory mechanisms controlling microcirculatory perfusion are classed as myogenic (sensing strain and stress), metabolic (regulation based on O~2~, CO~2~, lactate, and H^+^), and neurohumoral. This control system uses autocrine and paracrine interactions to regulate microcirculatory blood flow to meet the oxygen requirements of tissue cells. The endothelial cells lining the inside of the microvessels play a central role in this control system by sensing flow, metabolic, and other regulating substances to regulate arteriolar smooth-muscle-cell tone and capillary recruitment \[[@B4]\]. Endothelial cell-to-cell signaling transmits upstream information about hemodynamic conditions downstream \[[@B5]\]. The endothelium is also important in controlling coagulation and immune function, both of which directly affect and define microcirculatory function.

Regulatory dysfunction
----------------------

These autoregulatory mechanisms, and thus microcirculatory function, are severely disrupted during sepsis, and their dysfunction is a defining factor in the pathophysiology of sepsis \[[@B1]\]. Microcirculatory dysfunction is characterized by heterogeneous abnormalities in blood flow with some capillaries being underperfused, while others have normal to abnormally high blood flow \[[@B6]-[@B10]\]. Functionally vulnerable microcirculatory units become hypoxic, which explains the oxygen extraction deficit associated with sepsis \[[@B8],[@B9],[@B11]-[@B13]\]. In this condition, the microcirculatory partial pressure of O~2~(μpO~2~) drops below the venous pO2. This disparity has been termed the \"pO~2~gap\", a measurement of the severity of functional shunting, the occurrence of which is more severe in sepsis than in hemorrhage \[[@B12]-[@B14]\]. It is the main reason why monitoring systemic hemodynamic-derived and oxygen-derived variables is not able to sense such microcirculatory distress and mask this on-going process.

In sepsis, the microcirculatory endothelial cells are no longer able to perform their regulatory function because of disturbed signal transduction pathways and loss of electrophysiological communication and smooth muscle control \[[@B4],[@B5]\]. The nitric oxide (NO) system, a central component in the autoregulatory control of microcirculatory patency, is severely disturbed in sepsis by a heterogeneous expression of inducible nitric oxide synthase (iNOS) in different areas of organ beds, resulting in pathological shunting of flow \[[@B15],[@B16]\]. Since iNOS is not expressed homogeneously in organ systems, areas lacking iNOS have less NO-induced vasodilation and become underperfused. The smooth muscle cells that line the arterioles and regulate perfusion lose their adrenergic sensitivity and tone in sepsis \[[@B17],[@B18]\]. Red blood cells become less deformable and aggregate more \[[@B19]-[@B21]\]. Red blood cells also play an important role in the regulation of microcirculatory blood flow by their ability to release NO in the presence of hypoxia and cause vasodilation \[[@B22],[@B23]\]. This regulatory property of red blood cells may also be affected in sepsis. These severe defects, together with the disturbed coagulation during sepsis, further impede microcirculatory perfusion and function \[[@B15],[@B16]\]. Additionally, leukocytes activated by septic inflammation generate reactive oxygen species that directly disrupt microcirculatory structures, cellular interactions, and coagulatory function \[[@B24]-[@B26]\]. These and other inflammatory mediators alter barrier function in the microcirculation, including junctions between cells and possibly the endothelial glycocalyx, leading to tissue edema and further oxygen extraction deficit \[[@B27],[@B28]\]. Left uncorrected, microcirculatory dysfunction leads to respiratory distress of the parenchymal cells and resultant organ failure.

Mitochondrial distress
----------------------

Whether the primary cause of oxygen extraction deficit in sepsis is explained by the presence of shunted weak, hypoxic microcirculatory units or by mitochondria unable to process oxygen is a source of debate \[[@B12],[@B29],[@B30]\]. In a rat heart model of early sepsis, endotoxemia was observed to induce hypoxic areas in the microcirculation \[[@B12],[@B31]\]. However, in this model no mitochondrial dysfunction was found, as evidenced by the normal response of the mitochondrial energy state to hypoxia *in situ*\[[@B32]\]. It is likely that progress from early to severe sepsis is accompanied or even possibly caused by microcirculatory dysfunction, which leads to mitochondrial dysfunction with time. Brealey and colleagues \[[@B33]\] showed that mitochondrial dysfunction indeed plays an important role in sepsis where the level of respiratory dysfunction of mitochondria correlated with patient outcome. Mitochondrial failure associated with sepsis contributes to respiratory distress, especially in hypoxic areas \[[@B34]\], and can fuel tissue distress leading to organ dysfunction (Fig. [1](#F1){ref-type="fig"}).

Microcirculatory and mitochondrial distress syndrome
----------------------------------------------------

Resuscitation of the circulatory failure associated with sepsis based on correcting systemic hemodynamic- and oxygen-derived variables, but where regional and microcirculatory distress persist, has been termed microcirculatory and mitochondrial distress syndrome (MMDS) \[[@B35]\]. This concept has been formulated to identify the vulnerable physiological compartment masked from the systemic circulation and responsible for oxygen transport and cellular respiration that becomes dysfunctional in sepsis, and which can lead to organ failure (Fig. [1](#F1){ref-type="fig"}). The defining elements of the nature and severity of sepsis include the nature of the initial \"hit\" leading to sepsis, comorbidities, individual genetic makeup, previous therapy, and time to treatment.

The time the syndrome has persisted and the prior therapy received have a defining and modulating effect on the pathophysiology, and define the subclasses of the syndrome. The pathogenic nature of time was convincingly demonstrated by the study of Rivers and colleagues, where early treatment was shown to be associated with improved outcome \[[@B36]\]. This view of MMDS, where therapy and time are included in its definition, indicates that integrative evaluation of these determining factors of microcirculatory and mitochondrial function is needed for evaluation of the severity and nature of the syndrome in individual patients (Fig. [1](#F1){ref-type="fig"}).

Rescuing the microcirculation
=============================

The presence of microcirculatory distress, despite resuscitation based on hemodynamic and oxygen-derived endpoints, strongly suggests that microcirculatory failure is a key factor in the raised lactate levels, disturbed acid--base balance, and high gastric and/or oral CO~2~levels sometimes seen under such conditions. Microcirculatory failure can occur in the presence of normal or supranormal systemic hemodynamic- and oxygen-derived variables, with microcirculatory distress being masked from the systemic circulation by shunting pathways \[[@B2],[@B12]\]. Thus, monitoring techniques are required to verify that recruitment strategies for the microcirculation are indeed effective.

Monitoring the microcirculation to optimize treatment
-----------------------------------------------------

Several methods have been used to monitor microcirculatory function during circulatory failure in surgery and intensive care \[[@B37]\]. These include CO~2~measurements for sublingual, buccal, and subcutaneous microcirculatory CO~2~levels \[[@B38]-[@B41]\], as well as absorbance, reflectance and near infrared spectroscopy (NIRS), for measuring microcirculatory hemoglobin saturation \[[@B14],[@B42],[@B43]\]. Orthogonal polarization spectral (OPS) imaging after validation \[[@B44]\] was introduced by us into surgery and allowed the first direct observation of the microcirculation of human internal organs \[[@B45]-[@B48]\]. The technique allows microscopic visualization of the deeper lying microcirculation and the flow of red blood cells in the variably ordered microvessels of the microcirculation \[[@B45]\]. When applied sublingually, OPS provides a sensitivity and specificity for gauging the severity of the distributive defect in sepsis not achieved by conventional monitoring of systemic hemodynamic- or oxygen-derived variables \[[@B2]\]. Sublingual capnography combined with OPS imaging has been used to investigate the relationship between the microcirculation and metabolic state during resuscitation \[[@B38]\]. In cardiac surgery, simultaneous measurement of sublingual NIRS for deeper regional oxygenation, and reflectance spectrophotometry for measurement of superficial microcirculatory oxygen availability, gave integrative information about the redistribution of microcirculatory oxygenation occurring between these compartments during cardiac surgery. Such combinations, looking at different functional compartments of the microcirculation, can integratively ascertain the distributive alterations of oxygen transport during sepsis, septic shock, and therapy that are not provided by conventional monitoring of systemic hemodynamic- and oxygen-derived variables.

Studies by de Backer and colleagues \[[@B7]\], Spronk and colleagues \[[@B10]\], and Sakr and colleagues \[[@B2]\] on the sublingual microcirculation using OPS imaging in septic patients have directly associated the degree of microcirculatory distress with disease severity and response to therapy. These OPS studies have shown that the distributive defect associated with sepsis is characterized by obstructed stagnant blood flow in the smallest capillaries with near to normal flow in the larger microcirculatory vessels. This underlines the need to clinically monitor the blood flow in these small capillaries. OPS imaging is limited in this respect since OPS images of the capillaries are blurred and cannot always be detected. To this background we developed a new improved imaging modality for observation of the microcirculation called sidestream dark-field (SDF) imaging \[[@B49]\].

SDF imaging consists of a light guide, surrounded by 530 nm light-emitting diodes (LEDs), a wavelength of light that is absorbed by the hemoglobin of red blood cells, allowing their observation as dark cells flowing in the microcirculation (Fig. [2a](#F2){ref-type="fig"}; see <http://www.sdfimaging.net> for real-time movies). The LEDs at the tip of the guide are optically isolated from the inner image-conducting core, and pump light deep into the tissue, illuminating the microcirculation from within. This dark-field illumination applied from the side completely avoids tissue surface reflections, giving clear images of microcirculatory structures and red, as well as white, blood cell flow. The improved imaging of the leukocytes is shown in Fig. [2b](#F2){ref-type="fig"}. Such magnified images are providing new insights into cellular and microcirculatory properties at a level of detail not attained previously. It is expected that SDF imaging will improve the imaging modality for the microcirculation, especially for capillaries.

![Sidestream dark-field (SDF) imaging. This imaging technique is an improved method of observing the human microcirculation at the bedside. **(a)**SDF imaging consists of a light guide surrounded by green light-emitting diodes (LEDs; wavelength 530 nm) whose light penetrates the tissue and illuminates the microcirculation. The light is absorbed by hemoglobin of the red blood cells and scattered by leukocytes. A magnifying lens projects the image onto a video camera. Placed on organ surfaces, SDF imaging provides crisp images of the red blood cells and leukocytes flowing through the microcirculation (for real-time films, see <http://www.sdfimaging.net>). **(b)**As an example of the improved image quality provided by SDF imaging, the sublingual microcirculation of a volunteer is shown, with a magnified inset showing several leukocytes.](cc3753-2){#F2}

Therapeutic options
-------------------

Several therapeutic options are available for resuscitating the microcirculation in septic patients.

### Volume resuscitation

Relatively intact autoregulatory mechanisms ensure that resuscitation from hypovolemic shock through volume provision is effective in recruiting vulnerable microcirculatory beds \[[@B13],[@B50],[@B51]\]. Volume provision also restores microcirculatory barrier function and promotes microcirculatory oxygen transport \[[@B23],[@B50],[@B52]\]. However, hemodilution-induced hemodynamic effects can cause a redistribution of oxygen delivery away from weak microcirculatory units within organs, as well as between organs \[[@B14]\] and sublingual compartments \[[@B39],[@B43]\]. The significance of such redistribution of oxygen supply and its role in the pathophysiology of sepsis and resuscitation, however, has yet to be established. Blood is a much better oxygen carrier than colloid or crystalloid fluids and transfusion indeed improves oxygen delivery to the microcirculation more so than such fluids \[[@B53]\]. The age of stored red blood cells, however, can affect this property of blood and may need to be taken into account \[[@B53]\]. Hemoglobin-based oxygen carriers are also very effective oxygen carriers to the microcirculation but still need to be developed for routine clinical implementation \[[@B54]\].

### iNOS inhibitors and steroids

In sepsis, autoregulatory mechanisms are disturbed \[[@B55]\]. Simple fluid resuscitation, while effective in correcting systemic hemodynamics, can leave weak microcirculatory areas of the microcirculation hypoxemic \[[@B11],[@B12]\]. This pathological flow distribution \[[@B56]\] is related, among other mechanisms, to a heterogeneous expression of iNOS in different parts of organ beds resulting in pathological shunting of flow \[[@B15],[@B16]\]. Consequently, weak microcirculatory units need to be actively recruited, particularly under conditions of autoregulatory dysfunction. Of note is that iNOS-deficient mice do not exhibit the circulatory dysfunction associated with endotoxin that occurs in wild-type mice, underlining the importance of iNOS control in sepsis \[[@B57]\]. In recent studies in septic pigs, fluid combined with iNOS inhibition but not fluid alone, was successful in recruiting vulnerable microcirculatory beds in the intestine \[[@B50],[@B58]\]. Inhibition of iNOS also protects the barrier function of the microcirculation and can be regarded as a microcirculatory recruitment measure \[[@B59]\]. Anti-inflammatory agents such as steroids are highly effective at inhibiting iNOS and can prevent endotoxin-induced hypotension. Late timing of administration, however, does not have the beneficial inhibition of iNOS due to sepsis-evoked NO inhibition of the glucocorticoid receptor \[[@B60]\]. Such studies show the rationale of applying therapy early on. Steroids also improve autoregulatory function as observed in a rat model study of the autoregulatory properties of an isolated septic heart \[[@B55]\]. Most such experimental studies, however, use relatively high amounts of steroids, and clinical guidelines advise against the use of high levels of steroids in the treatment of sepsis \[[@B61]\]. Nevertheless, these studies indicate that reducing iNOS expression can be regarded as an important step in controlling the distributive hemodynamic defects of sepsis.

### Vasodilators and vasopressors

Recruitment of microcirculatory perfusion under normovolemia can be achieved by vasodilator therapy because this increases the driving pressure of blood flow at the entrance of the microcirculation \[[@B62]\]. In a porcine model of sepsis, NO donors in combination with fluids improved gut microcirculatory oxygenation and corrected gastric partial pressure of CO~2~(pCO~2~) whereas fluids alone did not \[[@B63]\]. In a clinical study in septic shock patients, where sublingual microcirculation was observed with OPS imaging, pressure-guided resuscitation resulted in attainment of flow in the larger vessels but not in the capillaries, where flow remained either sluggish or stagnant. This scenario directly visualizes the action of shunting pathways and identifies the microcirculation as the location of the distributive defect associated with sepsis. Vasodilator therapy by administration of nitroglycerin with adequate volume support, however, was able to recruit these stationary-flow capillaries and restore sublingual microcirculation \[[@B10]\]. De Backer and colleagues reported similar microcirculatory abnormalities in septic patients \[[@B7]\]. They further showed that the endothelial vasodilatory response was intact in septic patients by demonstrating that topical application of acetylcholine was effective in recruiting the shut-down capillaries. Sublingual OPS imaging studies in septic patients consistently found that, while pressure-guided resuscitation was effective in restoring systemic blood pressure, it did not by definition have such a correcting effect on microcirculatory perfusion \[[@B2]\].

From a microcirculatory perspective, vasopressors should be applied with caution and under conditions of microcirculatory monitoring. A study by Dubois and colleagues \[[@B34]\] reported that systemic blood pressure was restored by vasopressin in a distributive shock patient. Here, direct observation of sublingual microcirculation by OPS imaging showed no detrimental effect on microcirculatory perfusion. However, in another case--study of a septic shock patient, vasopressin, although effective in increasing blood pressure and urine output, caused a complete cessation of sublingual microcirculatory flow, constriction of the regional circulation, and death \[[@B64]\]. Animal experiments have also shown conflicting results: some studies have shown that vasopressin has beneficial effects on the renal microcirculation \[[@B65]\], while others have shown that vasopressin causes intestinal microcirculatory shutdown \[[@B66]\].

### Multiple-action therapy

Fluid resuscitation in combination with vasoactive and inotropic support is indeed effective in recruiting the microcirculation, although its effect on the microcirculation cannot be concluded on the measurement of systemic variables alone \[[@B2],[@B38]\]. Patients whose microcirculation is not responsive to such resuscitation, however, have a poor prognosis \[[@B2]\]. Recruitment of the microcirculation can be accomplished via different pathways and combination therapies can be expected to be beneficial. In this way, an NO donor agent can open the microcirculation and thereby perfuse weak microcirculatory units, while an anti-inflammatory agent or specific iNOS inhibitor can reduce pathological shunting and redirect blood flow to recruit weak microcirculatory units. This may appear paradoxical from a mechanistic stance, but both therapies are effective microcirculatory recruiting maneuvers \[[@B50],[@B65]\] and could theoretically be combined. It is clear that when applying such combinational therapies, their effectiveness in recruiting the microcirculation needs to be verified for the different organ systems.

Taking into consideration that resuscitated sepsis forms a multifactorial hit resulting in microcirculatory distress, drugs with multiple sites of action might provide an effective treatment strategy for recruiting microcirculatory function during sepsis. Activated protein C (APC) \[[@B67]\] provides just such an integrated approach by acting on different mechanisms involved in microcirculatory distress. It has been shown, for example, that APC inhibits iNOS expression and protects against endotoxin-induced hypotension \[[@B68]\]. Furthermore, through its action on nuclear factor-κB levels, APC also reduces the level of tumor necrosis factor, an effect not seen when iNOS inhibitors are administered alone \[[@B69]\]. In addition, APC reduces leukocyte activation and the release of reactive oxygen species, as well as acting on coagulatory pathways \[[@B70]\]. Several studies have shown by direct intravital observation that these multifactorial actions improve the microcirculation in septic animals \[[@B71],[@B72]\]. APC initiates a number of effects that, collectively, can be regarded as a rescue strategy for microcirculatory dysfunction in sepsis. However, several questions remain in respect to the mode of action of APC. What effect does the timing and dosage of APC have on the variables known to be beneficial to the microcirculation? How do different organs react to APC? How does the presence of other therapeutic agents affect the efficacy of APC to rescue the microcirculation? Direct observation and monitoring of the microcirculation should provide an insight into these issues and may even provide endpoints for the treatment of sepsis \[[@B73]\].

Conclusion
==========

In this review, we discuss the role of microcirculatory dysfunction in the development and treatment of the circulatory distributive defect associated with sepsis leading to organ failure. Conventional systemic hemodynamic- and oxygen-derived variables fail to detect such microcirculatory dysfunction and its response to the therapy. If left uncorrected, microcirculatory dysfunction can fuel cellular distress of the parenchymal cells and lead to organ dysfunction. From this perspective the microcirculation can indeed be regarded as the motor of sepsis. Recruitment maneuvers and monitoring of microcirculatory function are expected to contribute to the diagnosis and treatment of sepsis.
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